{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:49:53Z","timestamp":1771037393388,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijantimicag.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,8,11]],"date-time":"2013-08-11T08:30:16Z","timestamp":1376209816000},"page":"466-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Outpatient systemic antimycotic and antifungal use in Europe: New outcome measure provides new insight"],"prefix":"10.1016","volume":"42","author":[{"given":"Niels","family":"Adriaenssens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Versporten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2125.2004.02164.x","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach","volume":"58","author":"Vander Stichele","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0010","doi-asserted-by":"crossref","first-page":"vi3","DOI":"10.1093\/jac\/dkr453","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkq023","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe","volume":"65","author":"Adriaenssens","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0020","doi-asserted-by":"crossref","first-page":"vi37","DOI":"10.1093\/jac\/dkr456","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0025","doi-asserted-by":"crossref","first-page":"vi47","DOI":"10.1093\/jac\/dkr457","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0030","doi-asserted-by":"crossref","first-page":"vi25","DOI":"10.1093\/jac\/dkr455","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997\u20132009)","volume":"66","author":"Versporten","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0035","doi-asserted-by":"crossref","first-page":"vi13","DOI":"10.1093\/jac\/dkr454","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997\u20132009)","volume":"66","author":"Versporten","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0040","doi-asserted-by":"crossref","first-page":"vi57","DOI":"10.1093\/jac\/dkr458","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997\u20132009)","volume":"66","author":"Coenen","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0045","doi-asserted-by":"crossref","first-page":"vi79","DOI":"10.1093\/jac\/dkr460","article-title":"Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis","volume":"66","author":"Minalu","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0050","doi-asserted-by":"crossref","first-page":"vi89","DOI":"10.1093\/jac\/dkr461","article-title":"Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis","volume":"66","author":"Faes","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0055","doi-asserted-by":"crossref","first-page":"vi71","DOI":"10.1093\/jac\/dkr459","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of outpatient antibiotic use in Europe","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0060","series-title":"Guidelines for ATC classification and DDD assignment 2011","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2010"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0065","unstructured":"European Surveillance of Antimicrobial Consumption (ESAC) Management Team, ESAC Scientific Advisory Board and ESAC National Networks. ESAC yearbook 2009. Antwerp, Belgium: University of Antwerp, 2011. http:\/\/www.esac.ua.ac.be\/main.aspx?c=*ESAC2&n=50036 (accessed 28.05.2013)."},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0070","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jac\/dkl241","article-title":"Effect of fluconazole consumption on long-term trends in candidal ecology","volume":"58","author":"Blot","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0075","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.004_bib0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2006.11.017","article-title":"Risk of resistance associated with fluconazole prophylaxis: systematic review","volume":"54","author":"Brion","year":"2007","journal-title":"J Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T01:59:20Z","timestamp":1539482360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924857913002628"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient systemic antimycotic and antifungal use in Europe: New outcome measure provides new insight","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}